Delphine Courilleau
Papers
1
Total Citations
20
H-Index
1
About
Delphine Courilleau is a distinguished researcher in cardiovascular biology and mitochondrial medicine, whose work has significantly advanced our understanding of heart failure mechanisms. Her primary research focuses on the transcriptional coactivator PGC-1α, a master regulator of mitochondrial biogenesis and energy metabolism. In her landmark 2012 study, she developed a pioneering cardiac-specific robotized cellular assay that identified novel families of human ligands capable of inducing PGC-1α expression and mitochondrial biogenesis. This groundbreaking approach, which has garnered 20 citations, provided crucial insights into how mitochondrial dysfunction in heart failure can be therapeutically targeted. Courilleau’s major contribution lies in bridging high-throughput screening technology with cardiac pathophysiology, offering a platform to discover compounds that could restore energy metabolism in failing hearts. Her work has opened new avenues for treating conditions characterized by mitochondrial impairment, demonstrating that activating PGC-1α pathways represents a promising therapeutic strategy. Through her innovative methodologies and translational focus, Courilleau has established herself as a key figure in cardiac metabolism research, inspiring future investigations into mitochondrial-targeted therapies for cardiovascular disease.
Research Focus
Key Achievements
Top Papers
- 1